Esprinet

LSE:0NFS UK
Market Cap
$246.08 Million
€239.73 Million EUR
Market Cap Rank
#16401 Global
#316 in UK
Share Price
€4.65
Change (1 day)
+3.33%
52-Week Range
€3.57 - €6.54
All Time High
€14.66
About

Esprinet S.p.A., together with its subsidiaries, engages in the wholesale distribution of information technology (IT) products and consumer electronics in Italy, Spain, Portugal, and rest of Europe. The company distributes air conditioning, audio, DIY and gardening, electricity and lighting, gaming, mobility, navigation, networking, printing, sports and leisure, TV and home cinema, and video surv… Read more

Esprinet (0NFS) - Net Assets

Latest net assets as of September 2025: €376.16 Million EUR

Based on the latest financial reports, Esprinet (0NFS) has net assets worth €376.16 Million EUR as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.74 Billion) and total liabilities (€1.36 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €376.16 Million
% of Total Assets 21.65%
Annual Growth Rate 10.06%
5-Year Change 0.07%
10-Year Change 30.79%
Growth Volatility 13.29

Esprinet - Net Assets Trend (2003–2024)

This chart illustrates how Esprinet's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Esprinet (2003–2024)

The table below shows the annual net assets of Esprinet from 2003 to 2024.

Year Net Assets Change
2024-12-31 €389.25 Million +5.94%
2023-12-31 €367.41 Million -10.22%
2022-12-31 €409.22 Million +5.98%
2021-12-31 €386.12 Million -0.73%
2020-12-31 €388.96 Million +8.34%
2019-12-31 €359.02 Million +4.70%
2018-12-31 €342.90 Million +1.39%
2017-12-31 €338.19 Million +6.36%
2016-12-31 €317.96 Million +6.84%
2015-12-31 €297.61 Million +8.27%
2014-12-31 €274.87 Million +5.79%
2013-12-31 €259.83 Million +8.32%
2012-12-31 €239.88 Million +9.17%
2011-12-31 €219.72 Million +0.15%
2010-12-31 €219.40 Million +12.91%
2009-12-31 €194.31 Million +14.10%
2008-12-31 €170.30 Million +9.45%
2007-12-31 €155.60 Million +8.04%
2006-12-31 €144.03 Million +48.11%
2005-12-31 €97.24 Million +38.34%
2004-12-31 €70.29 Million +35.17%
2003-12-31 €52.00 Million --

Equity Component Analysis

This analysis shows how different components contribute to Esprinet's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 54.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings €21.52 Million 5.53%
Common Stock €7.86 Million 2.02%
Other Comprehensive Income €372.96 Million 95.82%
Total Equity €389.25 Million 100.00%

Esprinet Competitors by Market Cap

The table below lists competitors of Esprinet ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Esprinet's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 367,410,000 to 389,247,000, a change of 21,837,000 (5.9%).
  • Net income of 21,521,000 contributed positively to equity growth.
  • Other comprehensive income decreased equity by 11,790,000.
  • Other factors increased equity by 12,106,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €21.52 Million +5.53%
Other Comprehensive Income €-11.79 Million -3.03%
Other Changes €12.11 Million +3.11%
Total Change €- 5.94%

Book Value vs Market Value Analysis

This analysis compares Esprinet's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.60x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 4.42x to 0.60x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2003-12-31 €1.05 €4.65 x
2004-12-31 €1.42 €4.65 x
2005-12-31 €1.97 €4.65 x
2006-12-31 €2.80 €4.65 x
2007-12-31 €2.99 €4.65 x
2008-12-31 €3.34 €4.65 x
2009-12-31 €3.81 €4.65 x
2010-12-31 €4.29 €4.65 x
2011-12-31 €4.29 €4.65 x
2012-12-31 €4.64 €4.65 x
2013-12-31 €4.99 €4.65 x
2014-12-31 €5.21 €4.65 x
2015-12-31 €5.72 €4.65 x
2016-12-31 €6.09 €4.65 x
2017-12-31 €6.46 €4.65 x
2018-12-31 €6.57 €4.65 x
2019-12-31 €6.97 €4.65 x
2020-12-31 €7.61 €4.65 x
2021-12-31 €7.70 €4.65 x
2022-12-31 €8.17 €4.65 x
2023-12-31 €7.43 €4.65 x
2024-12-31 €7.78 €4.65 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Esprinet utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 5.53%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.52%
  • • Asset Turnover: 2.05x
  • • Equity Multiplier: 5.19x
  • Recent ROE (5.53%) is below the historical average (12.80%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2003 26.86% 1.06% 2.45x 10.39x €8.77 Million
2004 28.06% 1.30% 2.66x 8.12x €12.69 Million
2005 27.43% 1.64% 1.98x 8.47x €16.95 Million
2006 30.66% 1.98% 2.31x 6.68x €29.76 Million
2007 20.19% 1.29% 2.64x 5.91x €15.86 Million
2008 14.21% 1.02% 2.68x 5.20x €7.17 Million
2009 16.55% 1.52% 2.53x 4.31x €12.73 Million
2010 14.98% 1.49% 2.88x 3.49x €10.93 Million
2011 3.63% 0.38% 2.93x 3.26x €-14.00 Million
2012 9.73% 1.21% 2.82x 2.86x €-649.50K
2013 8.89% 1.13% 2.76x 2.85x €-2.89 Million
2014 9.91% 1.18% 2.64x 3.18x €-232.90K
2015 10.22% 1.13% 2.80x 3.24x €640.20K
2016 8.41% 0.88% 2.60x 3.69x €-5.03 Million
2017 7.78% 0.82% 2.58x 3.70x €-7.48 Million
2018 4.11% 0.39% 2.53x 4.13x €-20.14 Million
2019 6.48% 0.59% 2.32x 4.77x €-12.55 Million
2020 8.12% 0.70% 2.46x 4.71x €-7.28 Million
2021 11.44% 0.94% 2.44x 4.98x €5.57 Million
2022 11.57% 1.01% 2.50x 4.58x €6.42 Million
2023 -3.23% -0.30% 2.17x 5.00x €-48.62 Million
2024 5.53% 0.52% 2.05x 5.19x €-17.40 Million

Industry Comparison

This section compares Esprinet's net assets metrics with peer companies in the same industry.

Industry Context

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Esprinet (0NFS) €376.16 Million 26.86% 3.62x $152.48 Million
Nyfosa AB (0A0K) $13.33 Billion 16.69% 1.39x $961.70 Million
Tethys Oil AB (0A1V) $256.60 Million 6.51% 0.11x $122.95 Million
High Templar Tech Limited (0A2T) $12.04 Billion -3.01% 0.06x $258.24 Million
Strategy Inc (0A7O) $605.73 Million 3.00% 0.54x $37.86 Billion
NACON SASU (0A9N) $40.77 Million 2.41% 0.74x $7.35 Million
Antin Infrastructure Partners (0AA5) $32.26 Million 152.50% 1.23x $579.46 Million
Truecaller AB Series B (0AA7) $145.93 Million -10.64% 1.99x $271.46 Million
Brockhaus Technologies AG (0AAW) $315.34 Million 15.55% 1.46x $75.78 Million
Hyloris Pharmaceuticals S.A. (0AB6) $39.07 Million -39.37% 0.22x $71.96 Million
Kalray S.A. (0ABT) $54.02 Million -28.78% 0.63x $33.84 Million